Treatment of syringomyelia using uncultured umbilical cord mesenchymal stem cells: A case report and review of literature.

Author: AhnHyunjun, JungWon-Ju, LeeKye-Ho, LeeSang Yeon

Paper Details 
Original Abstract of the Article :
Syringomyelia is a disease caused by the formation of a cavity inside the spinal cord and is accompanied by such symptoms as pain, paresthesia, and urination and defecation disorders, and in severe cases causes various paralyses. Currently, there are only surgical methods for the treatment of syring...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9136562/

データ提供:米国国立医学図書館(NLM)

Treatment of Syringomyelia Using Uncultured Umbilical Cord Mesenchymal Stem Cells: A Case Report and Review of Literature

This study explores the potential of uncultured umbilical cord mesenchymal stem cells (UCMSCs) in treating syringomyelia, a condition characterized by fluid-filled cavities within the spinal cord. The study presents a case report, highlighting the use of UCMSCs as a promising therapeutic approach, along with a review of existing literature. The research offers insights into the potential of stem cell therapy for treating syringomyelia, a condition that can cause significant neurological impairment.

Uncultured Umbilical Cord Mesenchymal Stem Cells: A Novel Therapeutic Approach for Syringomyelia

This study presents a case report exploring the use of uncultured umbilical cord mesenchymal stem cells (UCMSCs) for treating syringomyelia. The case report, coupled with a review of relevant literature, suggests that UCMSCs may hold promise as a therapeutic option for syringomyelia. The research highlights the potential of stem cell therapy in addressing this challenging neurological condition, opening doors for further exploration and clinical trials.

Stem Cell Therapy: A Potential Solution for Syringomyelia

This study delves into the potential of stem cell therapy for syringomyelia, a complex neurological disorder. The use of uncultured umbilical cord mesenchymal stem cells (UCMSCs) is presented as a promising therapeutic approach, as evidenced by a case report and a review of existing literature. The study suggests that stem cell therapy may offer a novel treatment option for syringomyelia, potentially improving neurological function and quality of life for patients. Just as a camel adapts to the harsh desert environment, stem cell therapy may offer a way to adapt and regenerate damaged tissues, providing hope for individuals with syringomyelia.

Dr. Camel's Conclusion

This study offers a glimpse into the vast and intriguing world of stem cell therapy, showcasing its potential to address challenging neurological conditions like syringomyelia. The use of uncultured umbilical cord mesenchymal stem cells (UCMSCs) presents a promising therapeutic approach, offering hope for individuals seeking effective treatment options. Just as a camel navigates the vastness of the desert with unwavering determination, researchers continue to explore the potential of stem cell therapy to transform the landscape of neurological treatment.

Date :
  1. Date Completed n.d.
  2. Date Revised 2022-07-16
Further Info :

Pubmed ID

35662863

DOI: Digital Object Identifier

PMC9136562

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.